Clinical Trials Sponsored by Kai Hansen Foundation

Total 141 results

Bispebjerg Hospital
Larix A/S; Region Hovedstadens Apotek; Acarix; Kai Hansen Foundation; Kai Houmann...

Completed

Cost-effectiveness and Safety of the CADScorSystem in Patients With Symptoms Suggestive of Stable Coronary Artery Disease. (FILTER-SCAD)

Angina, Stable

Denmark, Sweden
Kaj Winther Hansen

Completed

Comparative Study of Turmeric Extract in Patients With Arthrosis.

Quality of Life | Arthralgia | Stiffness of Unspecified Joint, Not Elsewhere Classified | Disturbance of Activity and Attention

Denmark
Dr. Kai Jaquet
Abbott Medical Devices; Hansen Medical

Completed

Alster Man and Machine: Comparison of Manual and Mechanical Remote Robotic Catheter Ablation for Drug-Refractory Atrial Fibrillation

Atrial Fibrillation

Germany
McMaster University
Rick Hansen Foundation

Completed

Physical Activity Guidelines for People With Spinal Cord Injury (SCI)

Spinal Cord Injury

Canada
AKI Critical Care Research Foundation

Unknown

CRRTNet Registry- A Prospective Observational Registry (CRRT)

Continuous Renal Replacement Therapy

United States
Toronto Rehabilitation Institute
Rick Hansen Foundation

Completed

FES Therapy:Restoring Voluntary Grasping Function in Chronic SCI

Spinal Cord Injuries

Canada
Toronto Rehabilitation Institute
Rick Hansen Foundation; Ontario Neurotrauma Foundation

Terminated

Restoration of Upper Limb Function in Individuals With Sub-Acute Spinal Cord Injury (MCRCT)

Spinal Cord Injury

Canada
University of Manitoba
Manitoba Medical Service Foundation; Rick Hansen Foundation

Completed

Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males

Hypotension | Spinal Cord Injury

Canada
PETHEMA Foundation
Janssen Pharmaceutica

Recruiting

Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma (GEM-TECTAL)

High-Risk de Novo Multiple Myeloma

Spain
Nuwellis, Inc.
AKI Critical Care Research Foundation

Terminated

Ultrafiltration Therapy Registry Using Aquadex (ULTRA-Peds) (ULTRA-Peds)

Fluid Overload

United States
Kati Järvelä
Finnish Cultural Foundation

Completed

Effects of Hypertonic Saline-HES Solution on Extracellular Water in Cardiac Surgery Patients

Fluid Volume Disorder

Finland
Mun Wai Lee
Santen Oy

Recruiting

Dry Eye Management With 3% Diquafosol Before and After Cataract Surgery

Dry Eye

Malaysia
Rick Hansen Institute
University of Calgary; Alberta Paraplegic foundation

Unknown

Minocycline in Acute Spinal Cord Injury (MASC)

Spinal Cord Injuries

Canada, Australia
McGill University
Shriners Hospitals for Children; Rick Hansen Foundation; Fondation pour la Recherche...

Withdrawn

The Effect of Locomotor Training on Children With Incomplete Spinal Cord Injuries

Spinal Cord Injuries

Canada
ETOP IBCSG Partners Foundation
Janssen Pharmaceuticals

Recruiting

AMAZE-lung: Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI (AMAZE-lung)

Non Small Cell Lung Cancer

Spain, France, Switzerland, United Kingdom, Singapore, Italy, Netherlands
Pfizer
Janssen Alzheimer Immunotherapy (JAI) Research and Development, LLC

Completed

Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Spain, France, Germany
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Withdrawn

Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

Peptic Ulcer
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Completed

Role of Mosapride in Patients With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Taiwan
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Completed

Lansoprazole Versus Mosapride for Functional Dyspepsia

Functional Dyspepsia | Epigastric Pain Syndrome | Post Prandial Distress Syndrome

Taiwan
Royal Free Hospital NHS Foundation Trust
KCI Europe Holding B.V.

Terminated

Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa (HIDRA)

Hidradenitis Suppurativa

United Kingdom
University of Aarhus
Danish Child Cancer Foundation; ML Jørgensen og Gunnar Hansens Foundation

Completed

Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration

Methotrexate Induced Nephrotoxicity

Denmark
Fundacion SEIMC-GESIDA
Janssen, LP

Completed

Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject (DUAL)

HIV Infection

Spain
Royal Marsden NHS Foundation Trust
Janssen, LP

Recruiting

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients (ADAPT-P)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

United Kingdom
PETHEMA Foundation
Janssen, LP; Adknoma Health Research

Recruiting

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Multiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)

Spain
NEAT ID Foundation
Gilead Sciences; Janssen Pharmaceuticals

Active, not recruiting

The Late Presenter Treatment Optimisation Study (LAPTOP)

HIV/AIDS

Spain, Ireland, France, United Kingdom, Germany, Italy, Belgium
Royal Marsden NHS Foundation Trust
Janssen, LP

Unknown

Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma (iMYC)

Gastrooesophageal Cancer

United Kingdom
Elizabeth Glaser Pediatric AIDS Foundation
Janssen, LP

Active, not recruiting

Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir (NewHorizon)

HIV/AIDS

Cameroon, Kenya, Lesotho, Swaziland, Uganda
Alliance Foundation Trials, LLC.
Celgene; Janssen, LP

Withdrawn

Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM

Relapsed or Refractory Multiple Myeloma
Foundation for Liver Research
Janssen-Cilag B.V.

Completed

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms (ETIM)

Chronic Hepatitis C

Netherlands
University of Oxford
Bayer; Li Ka Shing Foundation

Recruiting

Reproductive Endocrinology Oxford Study (RepOx) (RepOx)

Polycystic Ovary Syndrome

United Kingdom
Laura Kair
The Gerber Foundation; Children's Miracle Network

Completed

Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes (Rx Milk)

Exclusive Breastfeeding | Breastfeeding Duration | Donor Milk Supplementation

United States
Majanka H. Heijenbrok-Kal, PhD
Netherlands Brain Foundation

Not yet recruiting

ABI-aftercare in Motion: Multidisciplinary Aftercare in the Home Environment in Patients With Acquired Brain Injury (ABI-motion)

Acquired Brain Injury
Fundacion SEIMC-GESIDA
Janssen-Cilag, S.A.

Completed

A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c) (DETOX)

HIV Infections

Spain
Fundacion SEIMC-GESIDA
Janssen-Cilag, S.A.

Completed

Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice (CoDAR)

HIV Infections

Spain
Centre Leon Berard
Janssen, LP; Fondation ARC

Recruiting

A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer (ABLE02)

Metastatic Breast Cancer

France
Alliance Foundation Trials, LLC.
Janssen Research & Development, LLC

Active, not recruiting

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Prostate Cancer

United States
Duke University
Prostate Cancer Foundation; Janssen Diagnostics, LLC

Completed

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Renal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Advanced MET Amplified Solid Tumor

United States
PETHEMA Foundation
Janssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.

Completed

Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Spain
PETHEMA Foundation
Janssen-Cilag, S.A.; Celgene-BMS; LIDESEC

Not yet recruiting

Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.

Multiple Myeloma

Spain
Singapore General Hospital
Janssen, LP; International Myeloma Foundation

Active, not recruiting

Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma

Multiple Myeloma | Myeloma

Singapore
Southern Illinois Healthcare Foundation
Janssen Scientific Affairs, LLC

Completed

A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir

HIV-1-infection
PETHEMA Foundation
Celgene; Pierre Fabre Medicament; Janssen, LP

Completed

Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old (GEM2012MENOS65)

Multiple Myeloma

Spain
Fogarty Clinical Research Inc.
Abbott Medical Devices; Helen Kay Foundation; Northern Michigan Hospital Foundation...

Unknown

Impact of Aspiration Thrombectomy During Carotid Stenting

Carotid Artery Stenosis

United States
University of Zurich
Swiss National Science Foundation; University Hospital, Zürich; Fresenius Kabi

Completed

Optimized Therapy in Severe Traumatic Brain Injured Patients

Traumatic Brain Injury | Coma

Switzerland
Instituto de Salud Carlos III
UBS Optimus Foundation; Armauer Hansen Research Institute, Ethiopia

Completed

Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia (VL&MNEthio)

Malnutrition | Visceral Leishmaniasis
University Hospital Southampton NHS Foundation...
Janssen-Cilag Ltd.

Completed

A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib (REMoDL-B)

Lymphoma, Large B-Cell, Diffuse

United Kingdom, Switzerland
National University Hospital, Singapore
Janssen, LP; International Myeloma Foundation

Unknown

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Relapse and / or Refractory Myeloma

Singapore, Hong Kong, Taiwan, Korea, Republic of
Population Council
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; Ministry of Health, Thailand and other collaborators

Completed

Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand

HIV Infections | Syphilis | Trichomonas Vaginitis | Chlamydia Trachomatis | Nesseria Gonorrhea

Thailand
University of British Columbia
Juvenile Diabetes Research Foundation; Janssen, LP

Recruiting

Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2) (UST1D2)

Type 1 Diabetes Mellitus

Canada
PETHEMA Foundation
Celgene; Janssen-Cilag Ltd.; TFS Trial Form Support

Completed

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

Multiple Myeloma

Spain

Clinical Trials Sponsored by Kai Hansen Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations